Literature DB >> 589072

Plasma androstenedione and oestrone levels in normal and osteoporotic postmenopausal women.

D H Marshall, R G Crilly, B E Nordin.   

Abstract

Plasma androstenedione and oestrone concentrations were measured in 72 postmenopasual women. The women included some who had undergone oophorectomy, some with osteoporosis, and normal controls; they were matched for years since menopause. Both hormone concentrations were significantly reduced in the women with osteoporosis. The women who had undergone oophorectomy had hormone concentrations intermediate between the normal and osteoporotic values. Oestrogen deficiency secondary to low androstenedione levels is a major risk factor in postmenopausal osteoporosis, and may be caused by failure of ovarian stromal androgen secretion or some abnormality in the pituitary-adrenal axis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 589072      PMCID: PMC1632123          DOI: 10.1136/bmj.2.6096.1177

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  The relationship between oestrogen status and bone loss in post-menopausal women.

Authors:  B E Nordin; A Horsman; R Brook; D A Williams
Journal:  Clin Endocrinol (Oxf)       Date:  1976       Impact factor: 3.478

2.  Post-menopausal osteopenia and osteoporosis.

Authors:  B E Nordin; J C Gallagher; J E Aaron; A Horsman
Journal:  Front Horm Res       Date:  1975       Impact factor: 2.606

3.  The crush fracture syndrome in postmenopausal women.

Authors:  J C Gallagher; J Aaron; A Horsman; D H Marshall; R Wilkinson; B E Nordin
Journal:  Clin Endocrinol Metab       Date:  1973-07

4.  Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age.

Authors:  D L Hemsell; J M Grodin; P F Brenner; P K Siiteri; P C MacDonald
Journal:  J Clin Endocrinol Metab       Date:  1974-03       Impact factor: 5.958

5.  Letter: Osteoporosis and androgens.

Authors:  I Holló; F Szalay; J Szücs; M Boross
Journal:  Lancet       Date:  1976-06-19       Impact factor: 79.321

  5 in total
  18 in total

1.  Endogenous sex hormones and bone mineral density among community-based postmenopausal women.

Authors:  S Murphy; K T Khaw; M J Sneyd; J E Compston
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

2.  Buserelin-mediated osteoporosis: effects of restoring estrogen on bone resorption and whole body calcium content in the rat.

Authors:  A Goulding; E Gold
Journal:  Calcif Tissue Int       Date:  1990-01       Impact factor: 4.333

3.  Bone mineral density in Addison's disease.

Authors:  J P Devogelaer; J Crabbé; C Nagant de Deuxchaisnes
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-18

4.  The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis.

Authors:  B J Riis; P Rødbro; C Christiansen
Journal:  Calcif Tissue Int       Date:  1986-06       Impact factor: 4.333

5.  Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.

Authors:  J C Gallagher; B L Riggs; J Eisman; A Hamstra; S B Arnaud; H F DeLuca
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

Review 6.  Postmenopausal osteoporosis.

Authors:  J C Stevenson; M I Whitehead
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

7.  Sex Steroid Hormones and Fracture in a Multiethnic Cohort of Women: The Women's Health Initiative Study (WHI).

Authors:  Jane A Cauley; Michelle E Danielson; Guru Rajesh Jammy; Doug C Bauer; Rebecca Jackson; Jean Wactawski-Wende; Rowan T Chlebowski; Kristine E Ensrud; Robert Boudreau
Journal:  J Clin Endocrinol Metab       Date:  2017-05-01       Impact factor: 5.958

8.  Treatment of spinal osteoporosis in postmenopausal women.

Authors:  B E Nordin; A Horsman; R G Crilly; D H Marshall; M Simpson
Journal:  Br Med J       Date:  1980-02-16

9.  Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency.

Authors:  B Lawrence Riggs; Sundeep Khosla; Elizabeth J Atkinson; Colin R Dunstan; L Joseph Melton
Journal:  Osteoporos Int       Date:  2003-07-18       Impact factor: 4.507

10.  Three-year calcitonin combination therapy for postmenopausal osteoporosis with crush fractures of the spine.

Authors:  J Szücs; C Horváth; E Kollin; M Szathmári; I Holló
Journal:  Calcif Tissue Int       Date:  1992-01       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.